Advisory Committees

Nature and Basis Statements of Conflict(s) of Interest for Voting Members of FDA Advisory Committee Members

The Agency is revising its procedures regarding the disclosure of conflicts of interest and waivers for voting advisory committee members in order to implement the requirements of section 795 of Pub. L. No. 109-97 (Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2006) (Nov. 10, 2005). This information is being provided as an interim measure to comply with the requirements of this law.

Arthritis Drugs Advisory Committee

November 29, 2006

Joan M. Bathon, M.D.

• 18 U.S.C. 208 waiver [ pdf ]
• Acknowledgement and Consent [ pdf ]

Patricia Chesney, M.D.

• 18 U.S.C. 208 waiver [ pdf ]
• Acknowledgement and Consent [ pdf ]

Thomas Lehman, M.D.

• 18 U.S.C. 208 waiver [ pdf ]
• Acknowledgement and Consent [ pdf ]

Louis Morris, Ph.D.

• 18 U.S.C. 208 waiver [ pdf ]
• Acknowledgement and Consent [ pdf ]

Christy Sanborg, M.D.

• 18 U.S.C. 208 waiver [ pdf ]
• Acknowledgement and Consent [ pdf ]

Dennis Turk, Ph.D.

• 18 U.S.C. 208 waiver [ pdf ]
• Acknowledgement and Consent [ pdf ]

Page updated: November 9, 2006